Scopus Presentation on Launch of Duet Therapeutics, its Wholly-Owned Subsidiary Focused on Immuno-Oncology https://duettx.com/wp-content/uploads/Scopus-BioPharma-Presentation-on-Launch-of-Duet-Therapeutics-at-H.C.-Wainwright-23rd-Annual-Global-Investment-Conference.mp4
Duet Therapeutics, a Scopus BioPharma Company (Mechanism of Action) https://duettx.com/wp-content/uploads/Duet-Therapeutics-a-Scopus-BioPharma-Company-Mechanism-of-Action.mp4